Solstein Capital’s ATI Physical Therapy, Inc. ATIP Stock Holding History

Solstein Capital’s Portfolio ATIP Stock Details ATIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-710	Closed	-$339K	–	522
2021 Q2	$339K	Buy	710 +323	+83%	+$160K	0.42%	68
2021 Q1	$193K	Buy	+387	New	+$212K	0.26%	103

Other funds holding ATIP

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Grosvenor Holdings Chicago, Illinois $512M AUM 19.57% 1-Year Est. Return

Knighthead Capital Management New York $1.52B AUM 19.8% 1-Year Est. Return

Bernzott Capital Advisors Camarillo, California $209M AUM 9.57% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Monarch Alternative Capital New York $1.63B AUM 125.01% 1-Year Est. Return

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Solstein Capital's ATIP Position: Q3 2021 in Review

Solstein Capital sold out of ATI Physical Therapy, Inc. (ATIP) in Q3 2021, closing a stake of 710 shares — an estimated $339K sold.

Solstein Capital first reported a position in ATIP in Q1 2021 and held it in 2 quarters. The position peaked at $339K in Q2 2021. 79 funds tracked by Wall St. Rank hold ATIP as of Q3 2021.

Solstein Capital reported no remaining ATI Physical Therapy, Inc. position as of Q3 2021 after selling out during the quarter.
Solstein Capital sold 710 ATI Physical Therapy, Inc. shares in Q3 2021, an estimated $339K.
Solstein Capital first reported a position in ATI Physical Therapy, Inc. in Q1 2021 and held it in 2 quarters.
Solstein Capital's ATI Physical Therapy, Inc. position peaked at $339K in Q2 2021.
79 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. as of Q3 2021.

Based on Solstein Capital's 13F filing for Q3 2021, filed 27 Oct 2021.